Clean & Clear

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Clean & Clear is a line of dermatology products owned by Johnson & Johnson used in acne treatment and keratolytic therapy. Contains benzoyl peroxide (10%) or salicylic acid (2%) as active ingredients.[1]

The brand was originally developed by Revlon as a line of sensitive skin personal care items from 1950s. "Clean and Clear" has been advertised in 1956 as new "deep skin-cleaning liquid" that "cleanse all five cell layers of your skin".[2]

The "Clean and Clear" name was based on products that contained no fragrance or dyes, and left no residue after rinsing. The original line featured shampoos, conditioners and facial skincare products. In 1991, Revlon sold Clean & Clear to Johnson & Johnson.[3]

In 1993, Clean & Clear adopted its current slogan, "Clean & Clear and Under Control". Johnson & Johnson repositioned Clean & Clear within the market, focusing on acne; the products are similar to their Neutrogena (which J&J bought in 1994[3]) line, but less expensive.

Their primary focus is on skincare of young women but has extended their range to include products treating a wider range of conditions, recently launching a line of products "SOFT" focused on facial moisturizing. Clean & Clear is currently available in 46 countries.

In June 2014 The U.S. Food and Drug Administration mentioned Clean & Clear (among other over-the-counter topical acne products like Proactiv, Neutrogena, MaxClarity, Oxy, Ambi, Aveeno) in a special safety announcement on products that might cause "rare but serious hypersensitivity reactions".[4]

External links[edit]

References[edit]

  1. ^ "CLEAN AND CLEAR ADVANTAGE ACNE CONTROL (benzoyl peroxide, salicylic acid) kit (Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc.)". Daily Med. 2012. Archived from the original on July 8, 2014. Retrieved 2014-07-08. 
  2. ^ "New! Revlon Clean and Clear". Pittsburgh Post-Gazette. February 12, 1956. Retrieved 2014-07-09. 
  3. ^ a b Hofmeister, Sallie (August 23, 1994). "Johnson To Acquire Neutrogena". The New York Times. Archived from the original on July 9, 2014. Retrieved 2014-07-09. 
  4. ^ "FDA Drug Safety Communication: FDA warns of rare but serious hypersensitivity reactions with certain over-the-counter topical acne products". Food and Drug Administration. June 25, 2014. Archived from the original on July 8, 2014. Retrieved 2014-07-08.